Literature DB >> 6882994

The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliability.

P Bech, A Gjerris, J Andersen, S Bøjholm, P Kramp, T G Bolwig, M Kastrup, L Clemmesen, O J Rafaelsen.   

Abstract

The reliability of the total scores on three rating scales (Melancholia Scale and the two Newcastle Scales) and the algorithms leading to the Feighner, Research Diagnostic Criteria, and the DSM-III subtypes of depression have been compared. The degree of inter-observer agreements for the various item-combinations was significantly higher than would be expected by chance. The average agreement for each assessment system ranged from 80 to 93 per cent. This 7 to 20 per cent lack of total agreement probably reflects the limitation of clinical assessments including the influence of halo effects.

Entities:  

Mesh:

Year:  1983        PMID: 6882994     DOI: 10.1192/bjp.143.1.58

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study.

Authors:  D Loldrup; M Langemark; H J Hansen; J Olesen; P Bech
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Rating scales measuring the severity of psychotic depression.

Authors:  S D Østergaard; A J Rothschild; A J Flint; B H Mulsant; E M Whyte; A K Leadholm; P Bech; B S Meyers
Journal:  Acta Psychiatr Scand       Date:  2015-05-27       Impact factor: 6.392

3.  Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.

Authors:  A Gjerris; E Widerlöv; L Werdelin; R Ekman
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

4.  Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

Authors:  Craig H Mallinckrodt; John G Watkin; Chaofeng Liu; Madelaine M Wohlreich; Joel Raskin
Journal:  BMC Psychiatry       Date:  2005-01-04       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.